Zydus Lifesciences has informed that the financial results of the company for Q4 2021-22 (January-March 2022) would be declared on May 20, 2022. Post results Q&A session through webinar (powered by Zoom) has been scheduled on the same day- May 20, 2022 at 5:00 pm. Sharvil Patel, Managing Director of the Company would be hosting the call and the details to join the call is provided in the attached file.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1663.10 |
| Dr. Reddys Lab | 1224.45 |
| Cipla | 1235.20 |
| Zydus Lifesciences | 929.25 |
| Lupin | 2310.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: